This inventor holds 1 USPTO granted patent. Top assignees: California Institute of Technology, The University of Tennessee Research Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4,629 
1 out of 788 
Years Active: 2026
Title: Katsuhiko Mitachi: Innovator in Cancer Treatment
Introduction
Katsuhiko Mitachi is a notable inventor based in Knoxville, TN (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. His work focuses on addressing disorders related to DPAGT1 function, which includes cancer and bacterial infections.
Latest Patents
Katsuhiko Mitachi holds 1 patent for his invention titled "DPAGT1 inhibitors of capuramycin analogues and their antimigratory activities of solid tumors." This patent provides compounds and methods for using these compounds to treat various disorders, particularly those associated with DPAGT1 function.
Career Highlights
Throughout his career, Katsuhiko Mitachi has been associated with prestigious institutions such as the University of Tennessee Research Foundation and the California Institute of Technology. His work at these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Katsuhiko Mitachi has collaborated with notable individuals in his field, including William M. Clemons, Jr. These collaborations have further enhanced his research and development efforts.
Conclusion
Katsuhiko Mitachi's innovative work in developing treatments for cancer showcases his dedication to improving health outcomes. His contributions to the field are significant and continue to inspire future research in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile